CARDIOVASCULAR JOURNAL OF AFRICA • Vol 26, No 5, October/November 2015
6
AFRICA
MONDAY 5 OCTOBER 2015
07h00–08h30 REGISTRATION
07h00–08h00
ASTRAZENECA-SPONSORED BREAKFAST SYMPOSIUM
Benefits of Ticagrelor:
A Yearoo, Mauritius
Overview on ATP IV guidelines:
M Krishnakumar, India
Venue: Hibiscus ballroom
Chairs: M Domah, Mauritius;
A Mocumbi, Mozambique
08h30–10h30 Session VI: Cardiovascular disease in Women:
Venue: Hibiscus ballroom
08h30–09h00 The spectrum of heart disease in pregnancy and implication for treatment and prevention of complications:
K Sliwa, South Africa
09h00–09h30 How to advise and manage women with cardiovascular disease on risks associated with pregnancy:
A Mbakwem, Nigeria
09h10–09h30 ‘Bridge’ mitral balloon valvotomy: expanding indications for balloon valvotomy in Africa:
G Yonga, Kenya
09h50–10h10 Management of anticoagulant therapy in pregnancy:
S Ba, Senegal
10h10–10h30 Panel discussion
10h30–11h30 TEA/COFFEE BREAK
Chairs:
R Jugessur, Mauritius; A Dzudie, Cameroon
Venue: Hibiscus ballroom
Chairs:
S Ba, Senegal; A Bonny, Cameroon
Venue: Barracuda
11h30–13h00
Session VII: The Pan-African Society of Cardiology/
International Society of Hypertension session on
hypertension in Africa
Session VIII : Recent advances in the management
valvular heart disease
11h30–11h50 Access to essential antihypertensive medications
in African countries: results from an international
survey:
P Bovet, Seychelles
Baseline characteristics and outcome of rheumatic
heart disease in REMEDY: implications for clinical
practice:
L Zuhlke, South Africa
11h50–12h10 The South African hypertension guideline – lessons for
other African countries:
B Rayner, South Africa
Utility of hand-held echocardiography devices in
screening for rheumatic heart disease:
P Lwabi, Uganda
12h10–12h30 The IFHA and ISH hypertension guidelines –
relevance to the proposed pan-African roadmap:
B Onwubere, Nigeria
Appropriate use of echocardiography to evaluate
valvular heart disease in Africa:
F Peters, South Africa
12h30–12h50 The progression of hypertension and CVD risk factors
in Africa:
A Schutte, South Africa
Surgery for chronic rheumatic valvular heart disease:
A ElSayed, Sudan
12h50–13h00 Panel discussion
Panel discussion
13h00–14h00 LUNCH AND MODERATED POSTER PRESENTATIONS
Chairs:
S Subahi, Sudan; G Yonga, Kenya
14h00–15h30
Session IX: Congenital and acquired heart diseases of the young:
Venue: Hibiscus ballroom
14h00–14h20 Recent advances in the management of congenital heart disease:
C Hugo-Hamman, Namibia
14h20–14h40 Neglected cardiovascular diseases in African children:
A Mocumbi, Mozambique
14h40–15h00 Findings from school-based screening studies for rheumatic heart disease and implications for clinical practice:
L Zuhlke, South Africa
15h00–15h20 Risk factors for NCDs in school children and what is to be done:
K Tibazarwa, Tanzania
15h20–15h30 Panel discussion
14h00–15h30
Oral abstract session II
Venue: Barracuda
Chairs:
M Ntsekhe, South Africa ; A Toure, Niger